Related references
Note: Only part of the references are listed.Current Therapy and Emerging Intravesical Agents to Treat Non-Muscle Invasive Bladder Cancer
Kelly K. Bree et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Bladder Cancer. Version 3.2020
Thomas W. Flaig et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
Ryan L. Steinberg et al.
JOURNAL OF UROLOGY (2020)
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guerin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guerin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial
Wei Shen Tan et al.
EUROPEAN UROLOGY (2019)
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018
Yair Lotan et al.
NATURE REVIEWS UROLOGY (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2019)
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non muscle-invasive bladder cancer: Interim results
Vignesh T. Packiam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Siamak Daneshmand et al.
JOURNAL OF UROLOGY (2018)
Role of Checkpoint Inhibition in Localized Bladder Cancer
Noah M. Hahn et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer
Eugene J. Pietzak
CURRENT UROLOGY REPORTS (2017)
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer
Tom J. H. Arends et al.
EUROPEAN UROLOGY (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non-Muscle-invasive Bladder Cancer in Intermediate-and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial
Eduardo Solsona et al.
EUROPEAN UROLOGY (2015)
Efficacy and Safety of MCNA in Patients with Nonmuscle Invasive Bladder Cancer at High Risk for Recurrence and Progression after Failed Treatment with bacillus Calmette-Guerin
Alvaro Morales et al.
JOURNAL OF UROLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder
Savino M. Di Stasi et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA
Siamak Daneshmand et al.
NATURE REVIEWS UROLOGY (2014)
Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature
Michael Rink et al.
EUROPEAN UROLOGY (2013)
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer
Keiji Inoue et al.
CANCER (2012)
Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2005)
Bacillus Calmette-Guerin versus epirubicin for primary. secondary or concurrent carcinoma in situ of the bladder: Results of a european organization for the research and treatment of Cancer-Genito-urinary Group phase III trial (30906)
TM De Reijke et al.
JOURNAL OF UROLOGY (2005)
Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
HW Herr et al.
JOURNAL OF UROLOGY (2001)
Share Paper
